StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
AGM/EGMApr 26, 2026, 05:31 AM

CGON to Hold Annual Meeting on June 4, 2026; Elects 2 Directors

AI Summary

CG Oncology, Inc. will hold its 2026 Annual Meeting of Stockholders virtually on Thursday, June 4, 2026, at 10:00 a.m. Pacific Time. Stockholders of record as of April 7, 2026, will vote on the election of two Class II directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2026, and advisory votes on executive compensation and its preferred frequency.

Key Highlights

  • Annual Meeting scheduled for June 4, 2026, at 10:00 a.m. Pacific Time.
  • Record date for voting is April 7, 2026.
  • Stockholders to elect two Class II directors until the 2029 Annual Meeting.
  • Ratification of Ernst & Young LLP as independent auditor for 2026.
  • Advisory vote on Named Executive Officers' compensation.
  • Advisory vote on frequency of executive compensation votes.
  • Meeting will be held virtually via live audio webcast.
  • Board recommends "FOR" all nominees and proposals.